Twist Bioscience Corporation (TWST) Misses Q3 EPS by 7c

Twist Bioscience Corporation (NASDAQ: TWST) reported Q3 EPS of ($0.82), $0.07 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $35 million versus the consensus estimate of $32.27 million.

GUIDANCE:

Twist Bioscience Corporation sees FY2021 revenue of $129-132 million, versus the consensus of $127 million.

For earnings history and earnings-related data on Twist Bioscience Corporation (TWST) click here.

You May Also Be Interested In

• Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
• Jasper Therapeutics (JSPR) Tops Q2 EPS by 18c
• Traws Pharma (TRAW) Tops Q2 EPS by 27c